Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 281

1.

Metagenomic Investigation of Torque Teno Mini Virus-SH in Hematological Patients.

Bal A, Oriol G, Josset L, Generenaz L, Sarkozy C, Sesques P, Salles G, Morfin F, Lina B, Becker J, Reynier F, Mallet F, Pachot A, Cheynet V, Brengel-Pesce K, Trouillet-Assant S.

Front Microbiol. 2019 Sep 18;10:1898. doi: 10.3389/fmicb.2019.01898. eCollection 2019.

2.

Optimized nested PCR enhances biological diagnosis and phylogenetic analysis of human parvovirus B19 infections.

Pichon M, Labois C, Tardy-Guidollet V, Mallet D, Casalegno JS, Billaud G, Lina B, Gaucherand P, Mekki Y.

Arch Virol. 2019 Nov;164(11):2775-2781. doi: 10.1007/s00705-019-04368-w. Epub 2019 Aug 10.

PMID:
31401693
3.

Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia.

Nicolas de Lamballerie C, Pizzorno A, Dubois J, Julien T, Padey B, Bouveret M, Traversier A, Legras-Lachuer C, Lina B, Boivin G, Terrier O, Rosa-Calatrava M.

Sci Rep. 2019 Aug 7;9(1):11493. doi: 10.1038/s41598-019-48013-7.

4.

Web-based analysis of adherence to influenza vaccination among French healthcare workers.

Pichon M, Gaymard A, Zamolo H, Bazire C, Valette M, Sarkozy F, Lina B.

J Clin Virol. 2019 Jul;116:29-33. doi: 10.1016/j.jcv.2019.04.008. Epub 2019 Apr 28.

PMID:
31082729
5.

Residual Activatability of Circulating Tfh17 Predicts Humoral Response to Thymodependent Antigens in Patients on Therapeutic Immunosuppression.

Dahdal S, Saison C, Valette M, Bachy E, Pallet N, Lina B, Koenig A, Monneret G, Defrance T, Morelon E, Thaunat O.

Front Immunol. 2019 Feb 5;9:3178. doi: 10.3389/fimmu.2018.03178. eCollection 2018.

6.

Which sample for the transport of mycoplasma, eSwab® or dry swab?

Pichon M, Gebeile R, Lina B, Jacquet G, Gaymard A.

Ann Biol Clin (Paris). 2019 Feb 1;77(1):95-98. doi: 10.1684/abc.2018.1407.

PMID:
30799304
7.

Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.

Pizzorno A, Terrier O, Nicolas de Lamballerie C, Julien T, Padey B, Traversier A, Roche M, Hamelin ME, Rhéaume C, Croze S, Escuret V, Poissy J, Lina B, Legras-Lachuer C, Textoris J, Boivin G, Rosa-Calatrava M.

Front Immunol. 2019 Jan 29;10:60. doi: 10.3389/fimmu.2019.00060. eCollection 2019.

8.

Baseline characteristics and clinical symptoms related to respiratory viruses identified among patients presenting with influenza-like illness in primary care.

Souty C, Masse S, Valette M, Behillil S, Bonmarin I, Pino C, Turbelin C, Capai L, Vilcu AM, Lina B, van der Werf S, Blanchon T, Falchi A, Hanslik T.

Clin Microbiol Infect. 2019 Sep;25(9):1147-1153. doi: 10.1016/j.cmi.2019.01.014. Epub 2019 Jan 29.

PMID:
30703528
9.

OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes.

Del Campo J, Pizzorno A, Djebali S, Bouley J, Haller M, Pérez-Vargas J, Lina B, Boivin G, Hamelin ME, Nicolas F, Le Vert A, Leverrier Y, Rosa-Calatrava M, Marvel J, Hill F.

NPJ Vaccines. 2019 Jan 23;4:4. doi: 10.1038/s41541-019-0098-4. eCollection 2019.

10.

Whole Genome Sequencing of A(H3N2) Influenza Viruses Reveals Variants Associated with Severity during the 2016⁻2017 Season.

Simon B, Pichon M, Valette M, Burfin G, Richard M, Lina B, Josset L.

Viruses. 2019 Jan 28;11(2). pii: E108. doi: 10.3390/v11020108.

11.

Acute flaccid myelitis caused by enterovirus D68: Case definitions for use in clinical practice.

Kramer R, Lina B, Shetty J.

Eur J Paediatr Neurol. 2019 Mar;23(2):235-239. doi: 10.1016/j.ejpn.2019.01.001. Epub 2019 Jan 11. Review.

PMID:
30670331
12.

Emergence of enterovirus D68 clade D1, France, August to November 2018.

Bal A, Sabatier M, Wirth T, Coste-Burel M, Lazrek M, Stefic K, Brengel-Pesce K, Morfin F, Lina B, Schuffenecker I, Josset L.

Euro Surveill. 2019 Jan;24(3). doi: 10.2807/1560-7917.ES.2019.24.3.1800699.

13.

The Nonstructural NS1 Protein of Influenza Viruses Modulates TP53 Splicing through Host Factor CPSF4.

Dubois J, Traversier A, Julien T, Padey B, Lina B, Bourdon JC, Marcel V, Boivin G, Rosa-Calatrava M, Terrier O.

J Virol. 2019 Mar 21;93(7). pii: e02168-18. doi: 10.1128/JVI.02168-18. Print 2019 Apr 1.

14.

Metagenomic Next-Generation Sequencing Reveals Individual Composition and Dynamics of Anelloviruses during Autologous Stem Cell Transplant Recipient Management.

Bal A, Sarkozy C, Josset L, Cheynet V, Oriol G, Becker J, Vilchez G, Sesques P, Mallet F, Pachot A, Morfin F, Lina B, Salles G, Reynier F, Trouillet-Assant S, Brengel-Pesce K.

Viruses. 2018 Nov 14;10(11). pii: E633. doi: 10.3390/v10110633.

15.

Influenza epidemics observed in primary care from 1984 to 2017 in France: A decrease in epidemic size over time.

Souty C, Amoros P, Falchi A, Capai L, Bonmarin I, van der Werf S, Masse S, Turbelin C, Rossignol L, Vilcu AM, Lévy-Bruhl D, Lina B, Minodier L, Dorléans Y, Guerrisi C, Hanslik T, Blanchon T.

Influenza Other Respir Viruses. 2019 Mar;13(2):148-157. doi: 10.1111/irv.12620. Epub 2019 Jan 18.

16.

Quality control implementation for universal characterization of DNA and RNA viruses in clinical respiratory samples using single metagenomic next-generation sequencing workflow.

Bal A, Pichon M, Picard C, Casalegno JS, Valette M, Schuffenecker I, Billard L, Vallet S, Vilchez G, Cheynet V, Oriol G, Trouillet-Assant S, Gillet Y, Lina B, Brengel-Pesce K, Morfin F, Josset L.

BMC Infect Dis. 2018 Oct 29;18(1):537. doi: 10.1186/s12879-018-3446-5.

17.

Microorganisms associated with respiratory syncytial virus pneumonia in the adult population.

Jeannoël M, Lina G, Rasigade JP, Lina B, Morfin F, Casalegno JS.

Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):157-160. doi: 10.1007/s10096-018-3407-3. Epub 2018 Oct 23.

PMID:
30353485
18.

Clinical management and viral genomic diversity analysis of a child's influenza A(H1N1)pdm09 infection in the context of a severe combined immunodeficiency.

Pichon M, Picard C, Simon B, Gaymard A, Renard C, Massenavette B, Malcus C, Monneret G, Morfin-Sherpa F, Valette M, Javouhey E, Millat G, Lina B, Josset L, Escuret V.

Antiviral Res. 2018 Dec;160:1-9. doi: 10.1016/j.antiviral.2018.10.009. Epub 2018 Oct 11.

PMID:
30315875
19.

Cost and burden of RSV related hospitalisation from 2012 to 2017 in the first year of life in Lyon, France.

Kramer R, Duclos A; VRS study group in Lyon, Lina B, Casalegno JS.

Vaccine. 2018 Oct 29;36(45):6591-6593. doi: 10.1016/j.vaccine.2018.09.029. Epub 2018 Sep 25.

PMID:
30266485
20.

How to manage chickenpox during pregnancy: case reports.

Gaymard A, Pichon M, Bal A, Massoud M, Buenerd A, Massardier J, Combourieu D, Guibaud L, Gaucherand P, Lina B, Mekki Y, Morfin F, Bolze PA.

Ann Biol Clin (Paris). 2018 Dec 1;76(6):669-674. doi: 10.1684/abc.2018.1385.

PMID:
30257814
21.

Molecular diversity and biennial circulation of enterovirus D68: a systematic screening study in Lyon, France, 2010 to 2016.

Kramer R, Sabatier M, Wirth T, Pichon M, Lina B, Schuffenecker I, Josset L.

Euro Surveill. 2018 Sep;23(37). doi: 10.2807/1560-7917.ES.2018.23.37.1700711.

22.

The NS Segment of H1N1pdm09 Enhances H5N1 Pathogenicity in a Mouse Model of Influenza Virus Infections.

Ferraris O, Casalegno JS, Frobert E, Bouscambert Duchamp M, Valette M, Jacquot F, Raoul H, Lina B, Ottmann M.

Viruses. 2018 Sep 17;10(9). pii: E504. doi: 10.3390/v10090504.

23.

Synergistic Effects of Influenza and Staphylococcus aureus Toxins on Inflammation Activation and Cytotoxicity in Human Monocytic Cell Lines.

Jeannoel M, Casalegno JS, Ottmann M, Badiou C, Dumitrescu O, Lina B, Lina G.

Toxins (Basel). 2018 Jul 11;10(7). pii: E286. doi: 10.3390/toxins10070286.

24.

Linking influenza epidemic onsets to covariates at different scales using a dynamical model.

Roussel M, Pontier D, Cohen JM, Lina B, Fouchet D.

PeerJ. 2018 Mar 8;6:e4440. doi: 10.7717/peerj.4440. eCollection 2018.

25.

Role of p53/NF-κB functional balance in respiratory syncytial virus-induced inflammation response.

Machado D, Pizzorno A, Hoffmann J, Traversier A, Endtz H, Lina B, Rosa-Calatrava M, Paranhos-Baccala G, Terrier O.

J Gen Virol. 2018 Apr;99(4):489-500. doi: 10.1099/jgv.0.001040. Epub 2018 Mar 5.

PMID:
29504924
26.

Influenza A viruses alter the stability and antiviral contribution of host E3-ubiquitin ligase Mdm2 during the time-course of infection.

Pizzorno A, Dubois J, Machado D, Cartet G, Traversier A, Julien T, Lina B, Bourdon JC, Rosa-Calatrava M, Terrier O.

Sci Rep. 2018 Feb 27;8(1):3746. doi: 10.1038/s41598-018-22139-6.

27.

Genetic characterization of respiratory syncytial virus highlights a new BA genotype and emergence of the ON1 genotype in Lyon, France, between 2010 and 2014.

Gaymard A, Bouscambert-Duchamp M, Pichon M, Frobert E, Vallee J, Lina B, Casalegno JS, Morfin F.

J Clin Virol. 2018 May;102:12-18. doi: 10.1016/j.jcv.2018.02.004. Epub 2018 Feb 6.

PMID:
29471266
28.

Pediatric renal transplantation: A retrospective single-center study on epidemiology and morbidity due to EBV.

Laurent A, Klich A, Roy P, Lina B, Kassai B, Bacchetta J, Cochat P.

Pediatr Transplant. 2018 May;22(3):e13151. doi: 10.1111/petr.13151. Epub 2018 Feb 11.

PMID:
29430795
29.

I (Influenza) will be back!

Lina B.

Anaesth Crit Care Pain Med. 2018 Feb;37(1):9-10. doi: 10.1016/j.accpm.2017.12.008. No abstract available.

PMID:
29362164
30.

Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study.

Lina B, Boucher C, Osterhaus A, Monto AS, Schutten M, Whitley RJ, Nguyen-Van-Tam JS.

Influenza Other Respir Viruses. 2018 Mar;12(2):267-278. doi: 10.1111/irv.12534. Epub 2018 Jan 15.

31.

Implementation of Alere i Influenza A & B point of care test for the diagnosis of influenza in an ED.

Trabattoni E, Le V, Pilmis B, Pean de Ponfilly G, Caisso C, Couzigou C, Vidal B, Mizrahi A, Ganansia O, Le Monnier A, Lina B, Nguyen Van JC.

Am J Emerg Med. 2018 Jun;36(6):916-921. doi: 10.1016/j.ajem.2017.10.046. Epub 2017 Oct 18.

PMID:
29137903
32.

Impact of the Respiratory Microbiome on Host Responses to Respiratory Viral Infection.

Pichon M, Lina B, Josset L.

Vaccines (Basel). 2017 Nov 3;5(4). pii: E40. doi: 10.3390/vaccines5040040. Review.

33.

Early oseltamivir therapy improves the outcome in critically ill patients with influenza: a propensity analysis.

Hernu R, Chroboczek T, Madelaine T, Casalegno JS, Lina B, Cour M, Argaud L; On behalf the “Flu in Lyon ICUs” Study Group.

Intensive Care Med. 2018 Feb;44(2):257-260. doi: 10.1007/s00134-017-4953-3. Epub 2017 Oct 12. No abstract available.

PMID:
29026934
34.

Estimation of seasonal influenza vaccine effectiveness using data collected in primary care in France: comparison of the test-negative design and the screening method.

Vilcu AM, Souty C, Enouf V, Capai L, Turbelin C, Masse S, Behillil S, Valette M, Guerrisi C, Rossignol L, Blanchon T, Lina B, Hanslik T, Falchi A.

Clin Microbiol Infect. 2018 Apr;24(4):431.e5-431.e12. doi: 10.1016/j.cmi.2017.09.003. Epub 2017 Sep 9.

35.

Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study.

Langevin S, Pichon M, Smith E, Morrison J, Bent Z, Green R, Barker K, Solberg O, Gillet Y, Javouhey E, Lina B, Katze MG, Josset L.

J Gen Virol. 2017 Oct;98(10):2425-2437. doi: 10.1099/jgv.0.000920. Epub 2017 Sep 8.

36.

Early estimates of 2016/17 seasonal influenza vaccine effectiveness in primary care in France.

Souty C, Vilcu AM, Capai L, van der Werf S, Valette M, Blanchon T, Lina B, Behillil S, Hanslik T, Falchi A.

J Clin Virol. 2017 Oct;95:1-4. doi: 10.1016/j.jcv.2017.08.002. Epub 2017 Aug 9.

PMID:
28818690
37.

Characterization of oseltamivir-resistant influenza virus populations in immunosuppressed patients using digital-droplet PCR: Comparison with qPCR and next generation sequencing analysis.

Pichon M, Gaymard A, Josset L, Valette M, Millat G, Lina B, Escuret V.

Antiviral Res. 2017 Sep;145:160-167. doi: 10.1016/j.antiviral.2017.07.021. Epub 2017 Aug 3.

PMID:
28780426
38.

Factors associated with non-persistence to oral and inhaled antiviral therapies for seasonal influenza: a secondary analysis of a double-blind, multicentre, randomised clinical trial.

Flicoteaux R, Protopopescu C, Tibi A, Blanchon T, Werf SV, Duval X, Mosnier A, Charlois-Ou C, Lina B, Leport C, Chevret S.

BMJ Open. 2017 Jul 10;7(7):e014546. doi: 10.1136/bmjopen-2016-014546.

39.

Mutations in the fusion protein heptad repeat domains of human metapneumovirus impact on the formation of syncytia.

Dubois J, Cavanagh MH, Terrier O, Hamelin MÈ, Lina B, Shi R, Rosa-Calatrava M, Boivin G.

J Gen Virol. 2017 Jun;98(6):1174-1180. doi: 10.1099/jgv.0.000796. Epub 2017 Jun 14.

PMID:
28613142
40.

The NS1 Protein from Influenza Virus Stimulates Translation Initiation by Enhancing Ribosome Recruitment to mRNAs.

Panthu B, Terrier O, Carron C, Traversier A, Corbin A, Balvay L, Lina B, Rosa-Calatrava M, Ohlmann T.

J Mol Biol. 2017 Oct 27;429(21):3334-3352. doi: 10.1016/j.jmb.2017.04.007. Epub 2017 Apr 20.

PMID:
28433538
41.

Performance of influenza case definitions for influenza community surveillance: based on the French influenza surveillance network GROG, 2009-2014.

Casalegno JS, Eibach D, Valette M, Enouf V, Daviaud I, Behillil S, Vabret A, Soulary JC, Benchaib M, Cohen JM, van der Werf S, Mosnier A, Lina B.

Euro Surveill. 2017 Apr 6;22(14). pii: 30504. doi: 10.2807/1560-7917.ES.2017.22.14.30504.

42.

Vaginal Neoplasia Induced by an Unusual Papillomavirus Subtype in a Woman with Inherited Chromosomally Integrated Human Herpesvirus Type 6A.

Pichon M, Gaymard A, Lebail-Carval K, Frobert E, Beaufils E, Chene G, Tommasino M, Lina B, Gaucherand P, Gautheret-Dejean A, Bonnafous P, Gheit T, Buenerd A, Lamblin G, Mekki Y.

Gynecol Obstet Invest. 2017;82(3):307-310. doi: 10.1159/000470907. Epub 2017 Apr 6.

PMID:
28380476
43.

Does seasonal vaccination affect the clinical presentation of influenza among the elderly? A cross-sectional analysis in the outpatient setting in France, 2003-2014.

Mosnier A, Daviaud I, Caini S, Berche H, Mansuy JM, van der Werf S, Cohen JM, Lina B; GROG network.

Vaccine. 2017 Apr 11;35(16):2076-2083. doi: 10.1016/j.vaccine.2017.02.067. Epub 2017 Mar 11.

44.

Influenza B burden during seasonal influenza epidemics in France.

Mosnier A, Daviaud I, Casalegno JS, Ruetsch M, Burugorri C, Nauleau E, Bui TT, Fleury H, Lina B, van der Werf S, Cohen JM; Regional Groups for Influenza Surveillance.

Med Mal Infect. 2017 Feb;47(1):11-17. doi: 10.1016/j.medmal.2016.11.006. Epub 2017 Jan 3.

PMID:
28062245
45.

Severe paediatric conditions linked with EV-A71 and EV-D68, France, May to October 2016.

Antona D, Kossorotoff M, Schuffenecker I, Mirand A, Leruez-Ville M, Bassi C, Aubart M, Moulin F, Lévy-Bruhl D, Henquell C, Lina B, Desguerre I.

Euro Surveill. 2016 Nov 17;21(46). doi: 10.2807/1560-7917.ES.2016.21.46.30402.

46.

A major impact of the influenza seasonal epidemic on intensive care units, Réunion, April to August 2016.

Filleul L, Ranoaritiana DB, Balleydier E, Vandroux D, Ferlay C, Jaffar-Bandjee MC, Jaubert J, Roquebert B, Lina B, Valette M, Hubert B, Larrieu S, Brottet E.

Euro Surveill. 2016 Nov 24;21(47). pii: 30405. doi: 10.2807/1560-7917.ES.2016.21.47.30405.

47.

Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France.

Loubet P, Lenzi N, Valette M, Foulongne V, Krivine A, Houhou N, Lagathu G, Rogez S, Alain S, Duval X, Galtier F, Postil D, Tattevin P, Vanhems P, Carrat F, Lina B, Launay O; FLUVAC Study Group.

Clin Microbiol Infect. 2017 Apr;23(4):253-259. doi: 10.1016/j.cmi.2016.11.014. Epub 2016 Nov 27.

48.

Immune signatures of protective spleen memory CD8 T cells.

Brinza L, Djebali S, Tomkowiak M, Mafille J, Loiseau C, Jouve PE, de Bernard S, Buffat L, Lina B, Ottmann M, Rosa-Calatrava M, Schicklin S, Bonnefoy N, Lauvau G, Grau M, Wencker M, Arpin C, Walzer T, Leverrier Y, Marvel J.

Sci Rep. 2016 Nov 24;6:37651. doi: 10.1038/srep37651.

49.

Involvement of an Arginine Triplet in M1 Matrix Protein Interaction with Membranes and in M1 Recruitment into Virus-Like Particles of the Influenza A(H1N1)pdm09 Virus.

Kerviel A, Dash S, Moncorgé O, Panthu B, Prchal J, Décimo D, Ohlmann T, Lina B, Favard C, Decroly E, Ottmann M, Roingeard P, Muriaux D.

PLoS One. 2016 Nov 4;11(11):e0165421. doi: 10.1371/journal.pone.0165421. eCollection 2016.

50.

Impact on antiviral resistance of E119V, I222L and R292K substitutions in influenza A viruses bearing a group 2 neuraminidase (N2, N3, N6, N7 and N9).

Gaymard A, Charles-Dufant A, Sabatier M, Cortay JC, Frobert E, Picard C, Casalegno JS, Rosa-Calatrava M, Ferraris O, Valette M, Ottmann M, Lina B, Escuret V.

J Antimicrob Chemother. 2016 Nov;71(11):3036-3045. Epub 2016 Jul 17.

PMID:
27432605

Supplemental Content

Support Center